A Pilot Study Assessing EmSam in Bipolar Depression
Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This pilot study will evaluate the efficacy of the monoamine oxidase inhibitor (MAOI)EmSam, a
selegiline transdermal system (STS), in bipolar depression.